Literature DB >> 29520093

Tissue-agnostic cancer drug pipeline grows, despite doubts.

Ken Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29520093     DOI： 10.1038/nrd.2018.6

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Public biotech in 2017-the numbers.

Authors:  Chris Morrison; Riku Lähteenmäki
Journal:  Nat Biotechnol       Date:  2018-07-06       Impact factor: 54.908

2.  FDA approves landmark tissue-agnostic cancer drug.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2018-12-28       Impact factor: 84.694

Review 3.  Tumor-Agnostic Treatment for Cancer: When How is Better than Where.

Authors:  Daniele Lavacchi; Giandomenico Roviello; Alberto D'Angelo
Journal:  Clin Drug Investig       Date:  2020-06       Impact factor: 2.859

4.  The Porto European Cancer Research Summit 2021.

Authors:  Ulrik Ringborg; Anton Berns; Julio E Celis; Manuel Heitor; Josep Tabernero; Joachim Schüz; Michael Baumann; Rui Henrique; Matti Aapro; Partha Basu; Regina Beets-Tan; Benjamin Besse; Fátima Cardoso; Fátima Carneiro; Guy van den Eede; Alexander Eggermont; Stefan Fröhling; Susan Galbraith; Elena Garralda; Douglas Hanahan; Thomas Hofmarcher; Bengt Jönsson; Olli Kallioniemi; Miklós Kásler; Eva Kondorosi; Jan Korbel; Denis Lacombe; José Carlos Machado; José M Martin-Moreno; Francoise Meunier; Péter Nagy; Paolo Nuciforo; Simon Oberst; Júlio Oliveiera; Maria Papatriantafyllou; Walter Ricciardi; Alexander Roediger; Bettina Ryll; Richard Schilsky; Grazia Scocca; Raquel Seruca; Marta Soares; Karen Steindorf; Vincenzo Valentini; Emile Voest; Elisabete Weiderpass; Nils Wilking; Amanda Wren; Laurence Zitvogel
Journal:  Mol Oncol       Date:  2021-09-13       Impact factor: 6.603

Review 5.  Molecular Diagnostics in Clinical Oncology.

Authors:  Anna P Sokolenko; Evgeny N Imyanitov
Journal:  Front Mol Biosci       Date:  2018-08-27

Review 6.  New clinical trial designs in the era of precision medicine.

Authors:  Elena Garralda; Rodrigo Dienstmann; Alejandro Piris-Giménez; Irene Braña; Jordi Rodon; Josep Tabernero
Journal:  Mol Oncol       Date:  2019-02-22       Impact factor: 6.603

Review 7.  Therapeutic Advances in Oncology.

Authors:  Jinsha Liu; Priyanka Pandya; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

Review 8.  New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary.

Authors:  Paweł Krawczyk; Jacek Jassem; Kamila Wojas-Krawczyk; Maciej Krzakowski; Rafał Dziadziuszko; Włodzimierz Olszewski
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

9.  Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.

Authors:  Samantha O Perakis; Sabrina Weber; Qing Zhou; Ricarda Graf; Sabine Hojas; Jakob M Riedl; Armin Gerger; Nadia Dandachi; Marija Balic; Gerald Hoefler; Ed Schuuring; Harry J M Groen; Jochen B Geigl; Ellen Heitzer; Michael R Speicher
Journal:  ESMO Open       Date:  2020-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.